Description
This advanced research blend combines 5mg of CJC-1295 No DAC (also known as Modified GRF 1-29), a synthetic analogue of GHRH, with 5mg of Ipamorelin, a highly selective ghrelin receptor agonist. In laboratory models, the concurrent administration of a GHRH analogue and a GH secretagogue is studied for its synergistic ability to amplify pulsatile growth hormone release while maintaining natural endocrine rhythms and avoiding prolactin or cortisol elevation.
Aura Research ensures precise formulation and >99% purity for both peptides, providing a reliable foundation for complex metabolic studies.
Specifications:
- Contents: CJC-1295 No DAC (5mg) + Ipamorelin (5mg)
- Purity: >99% (HPLC verified for both compounds)
- Format: Lyophilised powder
- Quantity: 10mg total peptide per vial
For laboratory research use only. Not for human or veterinary consumption.
Reviews
There are no reviews yet.